Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,766,960
-
Total 13F shares
-
17,386,191
-
Share change
-
+2,622,275
-
Total reported value
-
$2,539,343,386
-
Put/Call ratio
-
37%
-
Price per share
-
$146.04
-
Number of holders
-
206
-
Value change
-
+$349,378,221
-
Number of buys
-
123
-
Number of sells
-
91
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q3 2023
As of 30 Sep 2023,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by
206 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,386,191 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., STATE STREET CORP, PAULSON & CO. INC., FMR LLC, MARSHALL WACE, LLP, and ALLIANCEBERNSTEIN L.P..
This page lists
206
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.